Works by Turkina, Anna


Results: 49
    1
    2
    3
    4

    Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 11, p. 1236, doi. 10.1002/ajh.25628
    By:
    • Lauseker, Michael;
    • Bachl, Katharina;
    • Turkina, Anna;
    • Faber, Edgar;
    • Prejzner, Witold;
    • Olsson‐Strömberg, Ulla;
    • Baccarani, Michele;
    • Lomaia, Elza;
    • Zackova, Daniela;
    • Ossenkoppele, Gert;
    • Griskevicius, Laimonas;
    • Schubert‐Fritschle, Gabriele;
    • Sacha, Tomasz;
    • Heibl, Sonja;
    • Koskenvesa, Perttu;
    • Bogdanovic, Andrija;
    • Clark, Richard E.;
    • Guilhot, Joelle;
    • Hoffmann, Verena S.;
    • Hasford, Joerg
    Publication type:
    Article
    5
    6

    Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
    By:
    • Gambacorti-Passerini, Carlo;
    • Brümmendorf, Tim H.;
    • Kim, Dong-Wook;
    • Turkina, Anna G.;
    • Masszi, Tamas;
    • Assouline, Sarit;
    • Durrant, Simon;
    • Kantarjian, Hagop M.;
    • Khoury, H. Jean;
    • Zaritskey, Andrey;
    • Shen, Zhi-Xiang;
    • Jin, Jie;
    • Vellenga, Edo;
    • Pasquini, Ricardo;
    • Mathews, Vikram;
    • Cervantes, Francisco;
    • Besson, Nadine;
    • Turnbull, Kathleen;
    • Leip, Eric;
    • Kelly, Virginia
    Publication type:
    Article
    7

    Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 907, doi. 10.3109/10428194.2011.627480
    By:
    • Nicolini, Franck E.;
    • Masszi, Tamas;
    • Shen, Zhixiang;
    • Gallagher, Neil J.;
    • Jootar, Saengsuree;
    • Powell, Bayard L.;
    • Dorlhiac-Llacer, Pedro Enrique;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • Turkina, Anna
    Publication type:
    Article
    8
    9
    10
    11
    12

    P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969596.20821.8c
    By:
    • Kuzmina, Elena;
    • Lomaia, Elza;
    • Morozova, Elena;
    • Chelysheva, Ekaterina;
    • Shukhov, Oleg;
    • Petrova, Anna;
    • Chitanava, Tamara;
    • Vlasova, Yulia;
    • Sbityakova, Evgenia;
    • Makarova, Tayana;
    • Nemchenko, Irina;
    • Bykova, Anastasiya;
    • Gurianova, Margarita;
    • Kohno, Alina;
    • Turkina, Anna
    Publication type:
    Article
    13
    14
    15

    P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTATION STATUS FROM THE 3‐YEAR UPDATE OF THE OPTIC TRIAL: A DOSE‐OPTIMIZATION STUDY OF 3 STARTING DOSES OF PONATINIB.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969552.85501.cf
    By:
    • Cortes, Jorge;
    • Deininger, Michael;
    • Lomaia, Elza;
    • Moiraghi, Beatriz;
    • Undurraga, Soledad;
    • Pavlovsky, Carolina;
    • Chuah, Charles;
    • Sacha, Tomasz;
    • H. Lipton, Jeffrey;
    • Mccloskey, James;
    • Rousselot, Philippe;
    • Rosti, Gianantonio;
    • de Lavallade, Hugues;
    • Rojas, Christine;
    • Turkina, Anna;
    • Talpaz, Moshe;
    • Mauro, Michael;
    • Lu, Vickie;
    • Vorog, Alexander;
    • Apperley, Jane
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.

    Published in:
    Annals of Internal Medicine, 2018, v. 168, n. 7, p. 461, doi. 10.7326/M17-1094
    By:
    • Mahon, François-Xavier;
    • Boquimpani, Carla;
    • Kim, Dong-Wook;
    • Benyamini, Noam;
    • Clementino, Nelma Cristina D.;
    • Shuvaev, Vasily;
    • Ailawadhi, Sikander;
    • Lipton, Jeffrey Howard;
    • Turkina, Anna G.;
    • De Paz, Raquel;
    • Moiraghi, Beatriz;
    • Nicolini, Franck E.;
    • Dengler, Jolanta;
    • Sacha, Tomasz;
    • Takahashi, Naoto;
    • Fellague-Chebra, Rafik;
    • Acharya, Sandip;
    • Wong, Stephane;
    • Jin, Yu;
    • Hughes, Timothy P.
    Publication type:
    Article
    25

    Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.

    Published in:
    2018
    By:
    • Mahon, François-Xavier;
    • Boquimpani, Carla;
    • Kim, Dong-Wook;
    • Benyamini, Noam;
    • Clementino, Nelma Cristina D;
    • Shuvaev, Vasily;
    • Ailawadhi, Sikander;
    • Lipton, Jeffrey Howard;
    • Turkina, Anna G;
    • De Paz, Raquel;
    • Moiraghi, Beatriz;
    • Nicolini, Franck E;
    • Dengler, Jolanta;
    • Sacha, Tomasz;
    • Takahashi, Naoto;
    • Fellague-Chebra, Rafik;
    • Acharya, Sandip;
    • Wong, Stephane;
    • Jin, Yu;
    • Hughes, Timothy P
    Publication type:
    journal article
    26
    27
    28

    Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.

    Published in:
    2012
    By:
    • Nicolini FE;
    • Turkina A;
    • Shen ZX;
    • Gallagher N;
    • Jootar S;
    • Powell BL;
    • De Souza C;
    • Zheng M;
    • Szczudlo T;
    • le Coutre P;
    • Nicolini, Franck E;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    journal article
    29

    Expanding Nilotinib Access in Clinical Trials (ENACT).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 118, doi. 10.1002/cncr.26249
    By:
    • Nicolini, Franck E.;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L.;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    Article
    30

    Xerostomia and hyposalivation in patients with obstructive sleep apnoea.

    Published in:
    Clinical Otolaryngology, 2021, v. 46, n. 4, p. 782, doi. 10.1111/coa.13735
    By:
    • Makeeva, Irina Michajlovna;
    • Budina, Tatiana Vasilievna;
    • Turkina, Anna Yurjevna;
    • Poluektov, Mikhail Gurevich;
    • Kondratiev, Sergey Alexeevitch;
    • Arakelyan, Marianna Georgievna;
    • Signore, Antonio;
    • Amaroli, Andrea
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 589, doi. 10.1016/j.clml.2023.04.002
    By:
    • Aleshina, Olga A.;
    • Zakurdaeva, Kristina;
    • Vasileva, Anastasia N.;
    • Dubov, Sergey K.;
    • Dubov, Vitaly S.;
    • Vorobyev, Vladimir I.;
    • Butaev, Lev S.;
    • Sukhareva, Alena M.;
    • Gavrilova, Lubov V.;
    • Toropova, Inessa Yu.;
    • Popova, Marina O.;
    • Siniaev, Aleksandr A.;
    • Kulagin, Aleksandr D.;
    • Kaplanov, Kamil D.;
    • Petrenko, Andrei A.;
    • Ochirova, Oksana I.;
    • Karpova, Alina;
    • Chelysheva, Ekaterina Yu.;
    • Turkina, Anna G.;
    • Gurianova, Margarita A.
    Publication type:
    Article
    38
    39

    Analysis of the Mortality of Russian Patients With Chronic Myeloid Leukemia in the Multicenter EUTOS ELN Population-based Study (EUTOS-PBS).

    Published in:
    2020
    By:
    • Lazareva, Olga V.;
    • Turkina, Anna G.;
    • Chelysheva, Ekatarina Yu.;
    • Kulikovsky, Anton A.;
    • Galayko, Maria V.;
    • Senderova, Olga M.;
    • Pepeliaeva, Valentina M.;
    • Meresiy, Sergey V.;
    • Luchinin, Alexandr S.;
    • Milutina, Galina I.;
    • Gavrilova, Lyubov V.;
    • Avdeeva, Lyudmila B.;
    • Dasheeva, Elena B.;
    • Vinogradova, Olga Yu.;
    • Julhakyan, Hunan L.;
    • Kulikov, Sergey M.
    Publication type:
    journal article
    40

    Analysis of Mortality of the Multicenter Eutos Eln Population-Based Study (EUTOS-PBS) in Russian Patients with Chronic Myeloid Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S298, doi. 10.1016/j.clml.2019.07.252
    By:
    • Lazareva, Olga;
    • Turkina, Anna;
    • Chelysheva, Ekaterina;
    • Shukhov, Oleg;
    • Kulikovskiy, Anton;
    • Galayko, Maria;
    • Senderova, Olga;
    • Pepeliaeva, Valentina;
    • Meresiy, Sergey;
    • Luchinin, Alexander;
    • Milutina, Galina;
    • Gavrilova, Lubov;
    • Avdeeva, Lubov;
    • Dasheeva, Elena;
    • Vinogradova, Olga;
    • Kulikov, Sergey;
    • Julhakyan, Hunan
    Publication type:
    Article
    41
    42

    ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.233
    By:
    • Mahon, Francois-Xavier;
    • Boquimpani, Carla;
    • Takahashi, Naoto;
    • Benyamini, Noam;
    • Clementino, Nelma Cristina D.;
    • Shuvaev, Vasily;
    • Lipton, Jeffrey H.;
    • Turkina, Anna G.;
    • De Paz Arias, Raquel;
    • Moiraghi, Beatriz;
    • Nicolini, Franck E.;
    • Dengler, Jolanta;
    • Sacha, Tomasz;
    • Kim, Dong-Wook;
    • Fellague-Chebra, Rafik;
    • Tiwari, Ranjan;
    • Bouard, Catherine;
    • Hughes, Timothy P.
    Publication type:
    Article
    43
    44

    ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S222, doi. 10.1016/j.clml.2018.07.092
    By:
    • Hughes, Timothy P.;
    • Boquimpani, Carla;
    • Takahashi, Naoto;
    • Benyamini, Noam;
    • Clementino, Nelma Cristina D.;
    • Shuvaev, Vasily;
    • Merchant, Akil;
    • Lipton, Jeffrey H.;
    • Turkina, Anna G.;
    • De Paz Arias, Raquel;
    • Moiraghi, Beatriz;
    • Nicolini, Franck E.;
    • Dengler, Jolanta;
    • Sacha, Tomasz;
    • Kim, Dong-Wook;
    • Fellague-Chebra, Rafik;
    • Acharya, Sandip;
    • Chaturvedi, Shalini;
    • Bouard, Catherine;
    • Mahon, François-Xavier
    Publication type:
    Article
    45
    46
    47
    48
    49